Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$681 Sell
13
-23
-64% -$1.22K ﹤0.01% 726
2026
Q1
$1.99K Buy
+36
New +$1.95K ﹤0.01% 661

Other funds holding GSK

Kingdom Financial Group's GSK Position: Q2 2026 in Review

Kingdom Financial Group reduced its GSK (GSK) stake by 64% in Q2 2026, selling an estimated $1.22K and leaving 13 shares worth $681. The position accounts for ﹤0.01% of the portfolio, ranked #726.

Kingdom Financial Group first reported a position in GSK in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.99K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Kingdom Financial Group held 13 shares of GSK worth $681 as of Q2 2026.
  • Kingdom Financial Group sold 23 GSK shares in Q2 2026, an estimated $1.22K.
  • GSK made up ﹤0.01% of Kingdom Financial Group's portfolio in Q2 2026, its #726 holding.
  • Kingdom Financial Group first reported a position in GSK in Q1 2026 and has held it in 2 quarters since.
  • Kingdom Financial Group's GSK position peaked at $1.99K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Kingdom Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.